This new office enables Schulman to be closer to many of our clients and will help us better serve the research organizations located in this vibrant life sciences community.
Durham, North Carolina (PRWEB) June 11, 2015
Schulman Associates IRB, Inc., the industry-leading central IRB in customer service and technology, recently began build-out of its new office space on Laboratory Drive in Research Triangle Park, Durham, North Carolina. The location will house review board and administrative staff, including IT, operations and customer service professionals.
“This new office enables Schulman to be closer to many of our clients and will help us better serve the research organizations located in this vibrant life sciences community,” said Michael Woods, President, CEO and Institutional Official at Schulman.
The new space will feature state-of-the-art communication technology infrastructure, enabling robust and efficient discussions among Schulman’s diverse board membership, whose locations are spread across the continent. The technology hub will also help Schulman staff to communicate rapidly with clients and others within the organization in its unwavering commitment to deliver exceptional customer service.
Schulman also plans to create two flexible, multi-purpose meeting spaces dedicated to increasing collaboration across the organization and with others in the research community. These spaces will each accommodate 20-40 people.
The overall office space plan is designed to be bright, open and energetic, with a floor plan that encourages staff collaboration and teamwork.
Schulman anticipates the completion of the new office space later in July with occupancy occurring shortly thereafter.
About Schulman Associates IRB, Inc.
Schulman Associates IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services – including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services through its joint venture partner Provision Research Compliance Services, offering comprehensive solutions to improve overall quality standards for clinical studies and data integrity, and to maximize the protection of human subjects. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).